Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Respiratory Infections specialty page provides respiratory infection-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

RESPIRATORY INFECTIONS VIDEOS - Page 1

Treating <i>Pseudomonas</i> Infections With Zerbaxa or Avycaz
Panelists provide their perspective on the appropriate settings in which to use Zerbaxa (ceftolozane) or Avycaz (ceftazidime/avibactam) for Pseudomonas infections and reflect on which dosing methods are the safest.
<i>Pseudomonas</i> Infections: Secondary Approach to Treatment
Panelists discuss their personal approaches to treating Pseudomonas infections when an earlier strategy has failed, taking into consideration past treatments, a patient’s sepsis status, and timely decision making.
Pseudomonas Infections: Selecting Upfront Antibiotics
Panelists reflect on their personal upfront approaches to treating Pseudomonas infections before lab results return, considering monotherapy versus treatment cocktails and the inherent risks that need to be accounted for.  
Core Challenges in <i>Pseudomonas</i> Treatment Protocol
Marin Hristos Kollef, MD; Andrew Shorr, MD; Peter L. Salgo, M; and Jason Pogue, PharmD, BCPS-AQID, identify the core challenges present in the treatment protocol of Pseudomonas infections, such as nuances with the Centers for Medicare and Medicaid Services or end-of-life care.  
Exploring Appropriate Treatment Protocols for <i>Pseudomonas</i> Infections
Peter L. Salgo, MD; Marin Hristos Kollef, MD; Jason Pogue, PharmD, BCPS-AQID; Andrew Shorr, MD; and Yoav Golan, MD, share insight on appropriate treatment protocols regarding Pseudomonas infections, specifically those concerning the value of treating a patient versus the safety of other patients.
<i>Pseudomonas</i> Infections Continue to Acquire Resistance, Complicating Treatment
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; and Yoav Golan, MD, discuss Pseudomonas infections’ ability to evolve and acquire resistance to fluoroquinolones, polymyxins, aminoglycosides, and other such agents, complicating treatment approaches.
Classes and Agents Available to Treat <i>Pseudomonas</i> Infections
Peter L. Salgo, MD; Andrew Shorr, MD; Jason Pogue, PharmD, BCPS-AQID; and Marin Hristos Kollef, MD, consider the respective value of fluoroquinolones, polymyxins, and aminoglycosides as drug classes used to treat certain cases of Pseudomonas infections.
Fighting <i>Pseudomonas</i>: Impact On Patient Prognosis & Approaches to Combat Infection
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Andrew Shorr, MD; Marin Hristos Kollef, MD; and Yoav Golan, MD, reflect on the impact that Pseudomonas infections have on patients’ prognoses and outline the basic treatment approaches they take to combat these infections.